KCT0007388已完成未知
A Randomized, Double-blinded, Placebo-controlled, Multi-center Study to Investigate the Effect of L.lactis CKDB001 Administration on Liver Aminotransferases in Subjects with Nonalcoholic Fatty Liver Disease
Chong Kun Dang Bio0 个研究点目标入组 120 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 75(Year)（—）
- 性别
- All
入选标准
- •1) Voluntarily decides to participate in this clinical study and signs the informed consent
- •2) Men and women aged 19 to 75 years inclusive at the time of signing the informed consent
- •3) upper limit of normal (ULN) < ALT or AST = 5 x upper limit of normal (ULN)
排除标准
- •1) A history of significant alcohol abuse or chronic alcoholic consumption
- •2) Viral liver disease and other liver diseases that may affect the results
- •3) Regularly intake of probiotics, prebiotics, synbiotics, fermented milk products within 4 weeks before screening visit
- •4) Use of drugs historically associated with hepatic steatosis
- •5) Use of drugs for the treatment of NAFLD or NASH within 3 months prior to screening, etc.
研究者
相似试验
已完成
不适用
enzilumab Study in Healthy Korean SubjectsCodes for special purposesKCT0006851Telcon RF Pharmaceuticals20
尚未招募
不适用
A Randomized, Double-blinded, Placebo-controlled, Multi-center Phase 2 Study to Explore the Efficacy and Safety of Subcutaneous Injection EG-Myocin Immediately Before and After PCI in Patients with Acute ST-Elevation Myocardial Infarction (STEMI)KCT0004288Eyegene60
招募中
1 期
Trial to evaluate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia PatientsCOVID-19 Pneumonia PatientsMedDRA version: 23.1Level: LLTClassification code 10084401Term: COVID-19 respiratory infectionSystem Organ Class: 100000004862EUCTR2022-001152-42-BGShaperon, Inc.1,134
进行中（未招募）
1 期
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor TherapyEarly non-metastatic breast cancer and therapy-induced bone loss and fracturesMedDRA version: 21.1Level: PTClassification code 10065687Term: Bone lossSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 21.1Level: LLTClassification code 10006188Term: Breast cancer female NOSSystem Organ Class: 100000004864EUCTR2005-005275-15-ATAmgen Limited3,400
进行中（未招募）
1 期
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor TherapyEarly non-metastatic breast cancer and therapy-induced bone loss and fracturesMedDRA version: 21.1Level: PTClassification code 10065687Term: Bone lossSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 21.1Level: LLTClassification code 10006188Term: Breast cancer female NOSSystem Organ Class: 100000004864EUCTR2005-005275-15-SEAmgen Limited3,400